Schemes to promote indigenous manufacturing of high-end and high-precision medical devices (PLI, Medical Device Parks, SMDI)
Department of Pharmaceuticals’ schemes for indigenous production of high-end and high-precision medical devices: PLI, Medical Device Parks and SMDI
- The Department of Pharmaceuticals administers scheme components for indigenous manufacturing of high-end and high-precision medical devices.
- The scheme uses incentives on eligible incremental sales in four specified target segments for medical devices.
What happened
The Government implemented schemes under the Department of Pharmaceuticals to promote indigenous manufacturing of high-end and high-precision medical devices, including incentives for incremental sales, support for Medical Device Parks, and strengthening of the overall medical device industry through sub-schemes for clusters, import dependence reduction, capacity building, clinical studies support and promotion.
Background and earlier position
India’s medical-device industrial policy is being operationalised through a combination of production-linked incentives for incremental sales, park-based shared testing and warehousing infrastructure, and targeted sub-schemes to reduce import dependence and build clinical and cluster capacity.
Related dispatches
